COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area.

ABSTRACT:

Background

Cancer patients have been reported to be at higher risk of COVID-19 complications and deaths. We report the characteristics and outcome of patients diagnosed with COVID-19 during breast cancer treatment at Institut Curie hospitals (ICH, Paris area, France).

Methods

An IRB-approved prospective registry was set up at ICH on March 13, 2020, for all breast cancer patients with COVID-19 symptoms or radiologic signs. Registered data included patient history, tumor characteristics and treatments, COVID-19 symptoms, radiological features, and outcome. Data extraction was done on April 25, 2020. COVID-19 patients were defined as those with either a positive RNA test or typical, newly appeared lung CT scan abnormalities.

Results

Among 15,600 patients actively treated

SUBMITTER: Vuagnat P 

PROVIDER: S-EPMC7254663 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature